— Know what they know.
Not Investment Advice
Also trades as: 0HKD.L (LSE) · $vol 0M

AXGN NASDAQ

AxoGen, Inc.
1W: +0.9% 1M: +11.7% 3M: +17.0% YTD: +33.3% 1Y: +257.0% 3Y: +348.5% 5Y: +92.4%
$40.90
-0.41 (-0.99%)
 
Weekly Expected Move ±6.2%
$36 $38 $41 $44 $46
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 64 · $2.2B mcap · 52M float · 2.06% daily turnover · Short 47% of daily vol

Revenue Segmentation

By Geography

Income Trends

Revenue
$225M +20.2% ▲
5Y CAGR: +14.9%
Gross Profit
$167M +17.9% ▲
5Y CAGR: +13.0%
Operating Income
-$8M -138.8% ▼
Net Income
-$16M -57.6% ▼
EPS (Diluted)
$-0.34 -47.8% ▼
EBITDA
$192K -96.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$127M$139M$159M$187M$225M
YoY Growth+13.4%+8.8%+14.7%+17.8%+20.2%
Cost of Revenue$23M$30M$37M$45M$58M
Gross Profit$104M$109M$122M$142M$167M
Gross Margin82.0%78.5%76.6%75.8%74.3%
R&D Expenses$24M$26M$27M$28M$33M
SG&A Expenses$106M$113M$116M$117M$142M
Operating Expenses$130M$139M$143M$145M$175M
Operating Income-$25M-$30M-$21M-$3M-$8M
Operating Margin-20.0%-21.4%-13.5%-1.8%-3.5%
Interest Expense$1M$624K$3M$8M$8M
Income Before Tax-$27M-$29M-$22M-$10M-$16M
Tax Expense$0$0$0$0$0
Net Income-$27M-$29M-$22M-$10M-$16M
Net Margin-21.2%-20.9%-13.7%-5.3%-7.0%
EPS (Diluted)$-0.65$-0.69$-0.51$-0.23$-0.34
EBITDA-$21M-$23M-$13M$6M$192K
Shares Outstanding41M42M43M44M46M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms